ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 198

$1.2M Total Retail Price of All Prescriptions

Rank: 5 out of 198

801 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 801 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 801 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 21,687 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 1,305 1,106 1 3
FUROSEMIDE 1,161 956 2 5
LEVOTHYROXINE SODIUM 1,086 962 3 1
POTASSIUM CHLORIDE 904 769 4 9
SIMVASTATIN 888 760 5 2
WARFARIN SODIUM 662 578 6 7
CITALOPRAM HBR 631 551 7 20
DOXYCYCLINE HYCLATE 609 499 10 8 97
LISINOPRIL 548 487 9 6
AMLODIPINE BESYLATE 483 391 10 4
HYDROCHLOROTHIAZIDE 464 430 11 16
HYDROCODONE-ACETAMINOPHEN 451 358 S3 12 8
GABAPENTIN 444 346 13 14
PREDNISONE 434 366 14 29
TRAMADOL HCL 417 339 15 15
CARVEDILOL 417 349 15 24
MELOXICAM 364 326 17 30
METFORMIN HCL 360 327 18 13
MONOJECT INSULIN SAFETY SYRNG 344 344 10 19 118
ATENOLOL 337 325 20 17
GLYBURIDE 264 250 R 21 103
INSULIN SYRINGE 262 244 22 95
TRAZODONE HCL 262 199 22 50
ZOLPIDEM TARTRATE 250 207 24 22
METOPROLOL TARTRATE 247 244 25 10
ALLOPURINOL 240 213 26 23
LOSARTAN POTASSIUM 220 202 27 18
LOSARTAN-HYDROCHLOROTHIAZIDE 212 186 28 49
METOPROLOL SUCCINATE 210 201 29 11
CLONIDINE HCL 193 159 30 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 171 31 38
CYMBALTA 165 89 32 48
DIOVAN 164 119 33 34
WELCHOL 163 117 34 139
ZETIA 148 136 35 68
CELEBREX 144 90 36 59
FLUTICASONE PROPIONATE 142 119 37 39
LEVEMIR 138 131 38 140
KLOR-CON M10 136 111 39 125
OXYBUTYNIN CHLORIDE 135 103 40 89
VESICARE 133 96 41 77
AZITHROMYCIN 132 106 42 56
ROPINIROLE HCL 128 69 43 74
GEMFIBROZIL 128 123 43 110
SPIRONOLACTONE 125 105 45 37
PANTOPRAZOLE SODIUM 125 99 45 31
PRAVASTATIN SODIUM 123 117 47 19
ATORVASTATIN CALCIUM 123 117 47 12
SUCRALFATE 118 54 49 165
PREMARIN 118 108 R 49 101
AMOXICILLIN 118 101 49 130
NAMENDA 117 117 52 33
CLINDAMYCIN HCL 112 78 53 228
FENTANYL 110 93 S2 54 73
DIGOXIN 108 103 55 43
ESCITALOPRAM OXALATE 107 54 56 53
POLYETHYLENE GLYCOL 3350 107 102 56 41
FAMOTIDINE 106 68 58 57
OXYCODONE-ACETAMINOPHEN 104 75 S2 59 79
METOLAZONE 103 72 60 121
RANITIDINE HCL 102 78 61 54
RISPERIDONE 101 79 62 82
CLOPIDOGREL 101 83 62 42
KLOR-CON 10 100 71 64 131
PAROXETINE HCL 100 84 64 65
TAMSULOSIN HCL 96 71 66 27
PROAIR HFA 93 61 67 80
QUETIAPINE FUMARATE 92 78 68 76
DONEPEZIL HCL 91 78 69 28
CIPROFLOXACIN HCL 91 82 69 55
TORSEMIDE 89 73 71 75
GLIMEPIRIDE 87 75 72 35
NAPROXEN 85 46 73 133
BYSTOLIC 85 69 73 58
SERTRALINE HCL 84 64 75 25
ALENDRONATE SODIUM 83 83 76 21
IPRATROPIUM BROMIDE 82 80 77 134
LACTULOSE 79 67 78 181
SPIRIVA 77 37 79 63
ENALAPRIL MALEATE 77 76 79 51
NEXIUM 76 57 81 40
JANUVIA 74 73 82 86
LEVEMIR FLEXPEN 71 59 83 149
LANTUS 71 64 83 46
HUMULIN N 70 68 85 176
AMIODARONE HCL 69 63 86 119
LYRICA 69 52 86 91
PROPRANOLOL HCL 68 40 88 92
TRIAMTERENE-HCTZ 67 67 89 32
MECLIZINE HCL 67 39 89 129
ALBUTEROL SULFATE 66 65 91 113
ADVAIR DISKUS 65 54 92 47
DOXAZOSIN MESYLATE 65 55 92 96
VERAPAMIL ER 64 64 94 117
IBUPROFEN 64 33 94 124
CRESTOR 64 53 94 26
PHENYTOIN SODIUM EXTENDED 64 46 94 141
PLAVIX 63 59 98 66
SOTALOL 63 63 98 208
CARBIDOPA-LEVODOPA 63 63 98 71
TIZANIDINE HCL 62 29 101 171
OLANZAPINE 62 39 101 162
DIVALPROEX SODIUM 62 26 101 122
AVODART 62 49 101 184
ACETAMINOPHEN-CODEINE 62 14 S3 101 135
DIPHENOXYLATE-ATROPINE 61 55 106 191
BENICAR 59 58 107 100
LEXAPRO 59 35 107 204
OXYBUTYNIN CHLORIDE ER 59 43 107 109
NIASPAN 56 34 110 138
BENZTROPINE MESYLATE 55 13 R 111 273
CARBAMAZEPINE 52 12 112 282
TAMIFLU 51 47 113 286
AMITRIPTYLINE HCL 51 36 R 113 69
PROCHLORPERAZINE MALEATE 50 19 115 289
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.